China-based Luye Pharma Group announced that it is handing Singapore distribution and marketing rights to the schizophrenia drug Seroquel (quetiapine fumarate immediate-release tablets) and Seroquel sustained release tablets to DCH Auriga. No financials were disclosed.
Acquisition and Licensing History
Luye acquired exclusive rights to Seroquel from AstraZeneca via a USD 546 million licensing deal signed in July of 2018. The firm has done a number of licensing deals for the drug since, granting distribution and promotional rights to India-based Cipla Ltd, Moksha8 Pharmaceuticals, Alvogen Korea Co., Ltd, Zuellig Pharma, DKSH, Alter Pharma, and Laboratorios Bago for a slew of markets in Africa, Latin America, and the Asia-Pacific region.-Fineline Info & Tech
